(Received for publication September 2, 1993) A trifluoroacetamide analogue of siastatin B, (3S,4S,5JR,6iQ-6-(trifluoroacetamido) -4,5-dihydroxy-3-piperidinecarboxylic acid has been chemically synthesized. This compound, as well as the previously synthesized analogue, (3/£,4i?,5jR ,6i?)-6-(trifluoroacetamido) -3,4,5-trihydroxy-3- piperidinecarboxylic acid, showed marked inhibitory activity against /?-glucuronidase and significant inhibition of experimental pulmonary metastasis of the highly metastatic melanoma B 16.
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Many naturally occurring and synthetic azasugars are potent and specific inhibitors for enzymes associated with carbohydrate metabolism, and they have the potential to produce a number of kinds of beneficial therapeutic effects such as antihyperglycemic, antimetastatic, antifungal, and antiviral activities, etc}\ Recent studies2~8) have provided considerable evidence of increased levels of /?-glucuronidase activity in human tumors and suggested that jS-glucuronidase mayplay a role in the metastasis of tumor cells. A multifunctional piperidine, siastatin B (1) which was isolated as an inhibitor of neuraminidase and -glucuronidase by Umezawaet al.9) from a Streptomyces culture, resembles structurally sialic acid (7V-acetylneuraminic acid, 2) and glucuronic acid (3) . After achievement of the total synthesis10~12) of 1, we synthesized several branched-chain13'14) and chemically modified analogues15~19). Now, we have synthesized a trifluoroacetamide analogue of siastatin B, (3S,4£,5i?,6i?)-6-(trifluoroacetamido) -4,5- dihydroxy-3-piperidinecarboxylic acid (4) (Fig. 1 ). In the course of our study to investigate the relationships between structure and biological activity of analogues of 1, it was shown that the 3-hydroxy analogue 5 was a strong inhibitor140 of /?-glucuronidase and the 3,4-olefin analogue 615'18) weakly affected /?-glucuronidase. This led to the synthesis of 4 having no hydroxyl group at C-3, which resembles 3. Compound 4 and the previously synthesized analogue of 1, (3i?,4i?,5i?,6i?)-6-(trifluoroacetamido)-3,4,5-trihydroxy-3-piperidinecarboxylic acid (5)14), showed inhibitory effects of experimental pulmonary metastasis of B16 melanoma.
Synthesis
In the total synthesis1°~12> of 1, the stereospecific introduction of the carboxyl group was carried out via endocyclic nitro olefin obtained by base-catalyzed elimination of the acetoxy group of 7, as shownin t The correct clockwise numbering is employed for siastatin B and its analogues in this article according to IUPAC rules. Scheme1. In this synthesis, however, the trifluoroacetamide group in 8 was unstable under the conditions of base-catalyzed elimination. Thus, as shown in Scheme 2, we developed an alternative using the Wacker process20) oxidation of the enol ethers 10 and ll prepared by the one-carbon homologation of the ketone 9 using the Witting reaction. The starting (35,45,5R,6S)-l-(terr-butoxycarbonyl)-6-(trifluoroacetamido)-4,5-(isopropylidenedioxy)-3-piperidinol (8) obtained by the method described previously14), was oxidized with ruthenium tetraoxide to give 9 in a good yield. Reaction of9 in tetrahydrofuran (THF) with an excess of a solution of (benzyloxymethylene)triphenylphosphorane generated from (benzyloxymethyl)triphenylphosphonium chloride and phenyllithium in THFafforded (Z)-benzyloxy ether 10 and (is)-isomer ll in yields of 26 and 23%, respectively.
The stereochemistry around the double bonds in 10 and ll was tentatively determined by NOEexperiments. NOEwas observed between the olefin proton and the equatorial proton at C-2 in 10, while no such effect was observed in ll. Initial attempts to convert 10 and ll into the corresponding hydroxymethyl derivatives directly by catalytic hydrogenolysis2 1) utilizing palladium or Raney Ni were unsuccessful. However, oxidation of 10 and ll by the Wacker process using palladium chloride and copper (I) chloride in TV^-dimethylformamide-water (10: 1) gave the ester 12. Fig. 2 shows a possible reaction mechanism22) via the Wacker process. The boat conformations in 10 and ll should be predictable from the boat conformation of synthetic (2i?,35,45,5i?)-6-acetamido-l-(ter£-butoxycarbonyl)-4,5-(isopropylidenedioxy)-3-(nitromethyl)-3-piperidinol (13) determined previously by X-ray crystallographic analysis13). Small coupling constants (/= <2Hz) between 5-H and 6-H in the *H NMRspectra of 10 and ll in agreement with that of 13 also support the boat conformations of 10 and ll. The 7i-complex 14 is formed by attack of the palladium reagent from the less-hindered side. The unstable c-alkyl intermediate 15, formed by subsequent addition of water to the double bond, is transformed into the benzyl ester 12 by a 1,2-hydride shift and reductive elimination of the palladium. Catalytic hydrogenolysis of 12 with palladium on carbon afforded 16, which was converted into 4 by treatment with hydrogen chloride in 1,4-dioxane in a good yield.
Biological
Activities As shown in Table 1 , 4 inhibited /?-glucuronidase from bovine liver as strongly as 5. Compound 4, as well as 5, also showed weak inhibitory activity against a-glucosidase (yeast) and did not inhibit sialidases isolated from Streptococcus sp. and the A/Aichi/2/68 (H3N2) strain of influenza virus. On the other hand, ground-state binding to /?-glucuronidase and strongly inhibit the enzymatic reaction. Recent studies by Nakajima et al.2'6'25'26) proved that heparanase (endo-jS-glucuronidase) activity correlates with the lung colonization abilities of murine B16 melanoma cells by extracellular matrix degradation and is inhibited by heparanase inhibitors such as heparin, heparin derivatives, etc. It is suggested that 4 and 5 as glucuronidase inhibitors inhibit extracellular matrix degradation and/or modify cell-surface glycoconjugates of B16 melanomacells, resulting in the inhibition observed of experimental pulmonary metastasis of the highly metastatic B 1 6 line. Futher evaluation of the biological activities of these compoundsis under investigation.
E x periment al General Methods
Melting points were determined with a Yanagimoto apparatus and were unconnected. IR spectra were determined on a Hitachi Model 260-10 spectrophotometer. Optical rotations were measured with a Perkin-Elmer Model 241 polarimeter. XHNMRspectra were recorded with a JEOL JNMEX270 spectrometer. Chemical shifts are expressed in S values (ppm) with tetramethylsilane as an internal standard. 
Experimental Metastasis Assay23'240
The highly metastatic melanoma B16 cells (3 x 105 cells) were cultured in Dulbecco's modified Eagle's mediumsupplemented with fetal bovine serum under 5%CO2at 37°C for 24 hours. Cells were incubated with (or without) each test compoundunder the same condition for 72 hours. After treatment with 0.05% trypsin and 0.02% EDTAsolution, a cell suspension containing 1 x 106 cells in 1 ml ofdivalent cation-free Dulbecco's phosphate-buffered saline was prepared. Cell (1 x 105 in 0.1 ml) were injected intravenously into the tail vein of each mouse (male BDF1?7 weeks old). Fourteen days later, after tumor cell implantation, the mice were autopsied. The numberof pulmonary tumor nodules was counted. Inhibition (%) ofmetastasis was calculated from the ratio of tumor nodules in treated and control experiments. (1 1) A solution of RuO4 in CC14 prepared from RuO2 (260mg) and NaIO4 (400mg) in a mixture of H2O (38ml) and CC14 (38ml) was added to a solution of 814) (140mg) in CH2C12 (5ml) until the appearance of a yellow color, and the mixture was stirred at room temperature for 15 minutes. After being quenched with 2-propanol (4ml), the mixture was diluted with CH2C12. The solution was washed with water, dried over MgSO4,and filtered. Evaporation of the filtrate gave an oil. The resulting oil was subjected to preparative TLC on silica gel, developing with CHC13 -MeOH(20 : 1), to give 9 (1 14mg) as an amorphous solid. To a cooled ( -68°C), stirred solution of (benzyloxymethyl)triphenylphosphonium chloride (1.82 g) in THF(3.5ml) under Ar was added dropwise a 1.8m solution of phenyllithium in hexane-ether (7 : 3) (2. 15 ml), and the mixture was stirred for 10 minutes. To the resulting solution of (benzyloxymethylene)-triphenylphosphorane was added dropwise a solution of 9 (114mg) in THF(l ml) at -68°C, and the mixture was allowed to warm to 10°C with continuous stirring during 4.5 hours. After being quenched with saturated NH4C1solution, the aqueous mixture was extracted with CH2C12.The extract was washed with water, dried over MgSO4,and filtered. Evaporation of the filtrate gave an oil. The oil was subjected to preparative TLC on silica gel, developing with toluene-acetone (5 : 1), to give 10 (37mg, 25.5%) and ll (33mg, 22.8%) as colorless foams.
10: [a]£6 +13°(c0.31, MeOH); IR (CHC13) 3450, 3000, 2950, 1735, 1700, 1680, 1530, 1470, 1405, 1395, 1390, 1305, 1270, 1170, 1090, 970, 870cm"1; : 3425, 3025, 2980, 2940, 2900, 1735, 1700, 1520, 1460, 1395, 1390, 1370, 1305, 1250, 1170, 1080, 1020, 970, 950, 920, A) From ll: A mixture of PdCl2 (10.2mg) and CuCl (46.2mg) in DMF-H2O (10: 1, 0.3ml) was stirred at room temperature for 1 hour under oxygen atmosphere, then ll (29.5 mg) was added. The mixture was stirred at 70°C for 25 hours and furthermore at room temperature for 61 hours, and the insoluble material was removed by filtration. Evaporation of the filtrate gave an oil, which was dissolved in EtOAc. The solution was washed with saturated aqueous NaHCO3and H2O, dried over MgSO4,and filtered. Evaporation of the filtrate gave an oil. The oil was subjected to preparative TLCon silica gel, developing with toluene-acetone (5 : 1) (35,4*S' , 5i?,6i?)-6-(Trifluoroacetamido)-4, 5-dihydroxy-3-piperidinecarboxylic Acid (4) Compound 16 (16.8 mg) was dissolved in 4m hydrogen chloride in dioxane (0.33 ml), and the mixture was stirred at room temperature overnight. Another portion of 4 mhydrogen chloride in dioxane (0. 17 ml) was added to the mixture and then the reaction mixture was further stirred at roomtemperature for 1.5 hours. The resulting precipitates were collected by filtration and washed with dioxane to give a colorless amorphous solid of4 as its hydrochloride (12.1 mg, 96.2%): mp 130°C (dec); [a]^1 +27°(c 0.22, H2O); IR (KBr) 3425, 2950 , 2830 , 2780 , 2490 , 1740 , 1725 , 1715 , 1630 , 1555 , 1465 , 1440 , 1410 , 1360 , 1330 , 1310 , 1280 , 1230 (sh), 1210 , 1200 , 1180 , 1160 , 1095 , 1030 , 1010 XH NMR (D2O) S 2.92 (1H, ddd, /=2.3, 8 and 10Hz, 3-H), 3.32-3.39 (2H, m, 2-H2), 3.96 (1H, dd, .7=2.6 and 10.6Hz, 4.42 (1H, t, .7=2.3 Hz, 4-H) and 5.01 (1H, d, /= 10.6Hz, 6-H); FAB-MS (positive) m/z 273 (M-fH)+, 207, 160, 141, 115, 75 and 57. 
